Gossamer Bio Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$480M
Industry:Biotech
Founded:2017
Lead Investor(s):Hillhouse Capital
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Gossamer Bio's estimated revenue is currently $6M per year.
  • Gossamer Bio received $230.0M in venture funding in July 2018.
  • Gossamer Bio's estimated revenue per employee is $53496
  • Gossamer Bio's total funding is $480M.

Employee Data

  • Gossamer Bio has 113 Employees.
  • Gossamer Bio grew their employee count by 190% last year.
  • Gossamer Bio currently has 12 job openings.

What Is Gossamer Bio?

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio's strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

keywords:N/A

113

Number of Employees

$6M

Revenue (est)

12

Current Jobs

190%

Employee Growth %

$480M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Mission Bio
$7.4M6944%
Rigel Pharmaceu...
$40.5M2714%
ProTrials Resea...
$25.6M1703%
Advanced Cell D...
$23.9M1668%
CellMax Life
$10M379%$9M
Atreca
$10.7M8117%
Full Spectrum A...
$5.7M395%
Pipette.com/Acc...
N/AN/A
Irvine Scientif...
$29.1M2059%
Talis Biomedica...
$8.1M544%

Gossamer Bio News

09/07/2019 - Implied Volatility Surging for Gossamer Bio (GOSS) Stock ...

Investors in Gossamer Bio, Inc. GOSS need to pay close attention to the stock based on moves in the options market lately. That is because the ...

09/08/2019 - Gossamer Bio Inc (NASDAQ:GOSS) Shares Sold by Artal ...

Artal Group S.A. trimmed its position in Gossamer Bio Inc (NASDAQ:GOSS) by 3.0% in the 2nd quarter, according to the company in its most ...

09/05/2019 - Luisa Salter-Cid Is The Chief Scientific Officer of Gossamer ...

Some Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders may be a little concerned to see that the Chief Scientific Officer, Luisa Salter-Cid, ...

Gossamer Bio Funding

DateAmountRoundLead InvestorsReference
2018-01-08$100.0MUndisclosedOmega FundsArticle
2018-07-24$230.0MHillhouse CapitalArticle

Gossamer Bio Executive Hires

DateNameTitleReference
2018-07-24Sheila GujrathiChief Executive Officer, and Co-FounderArticle
2018-09-06Luisa Salter-CidChief Scientific OfficerArticle
2018-12-18Jakob DupontChief Medical OfficerArticle